Publication: BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.
| dc.contributor.author | Zong, Dali | |
| dc.contributor.author | Adam, Salomé | |
| dc.contributor.author | Wang, Yifan | |
| dc.contributor.author | Sasanuma, Hiroyuki | |
| dc.contributor.author | Callén, Elsa | |
| dc.contributor.author | Murga, Matilde | |
| dc.contributor.author | Day, Amanda | |
| dc.contributor.author | Kruhlak, Michael J | |
| dc.contributor.author | Wong, Nancy | |
| dc.contributor.author | Munro, Meagan | |
| dc.contributor.author | Ray Chaudhuri, Arnab | |
| dc.contributor.author | Karim, Baktiar | |
| dc.contributor.author | Xia, Bing | |
| dc.contributor.author | Takeda, Shunichi | |
| dc.contributor.author | Johnson, Neil | |
| dc.contributor.author | Durocher, Daniel | |
| dc.contributor.author | Nussenzweig, André | |
| dc.contributor.funder | Ministerio de Educación, Cultura y Deporte (España) | |
| dc.contributor.funder | United States Department of Health and Human Services | |
| dc.contributor.funder | Lawrence Ellison Foundation | es_ES |
| dc.contributor.funder | United States Department of Defense | |
| dc.contributor.funder | Alex's Lemonade Stand Foundation | es_ES |
| dc.contributor.funder | NIH - National Cancer Institute (NCI) (Estados Unidos) | |
| dc.contributor.funder | Rutgers Cancer Institute | es_ES |
| dc.date.accessioned | 2024-02-09T11:34:00Z | |
| dc.date.available | 2024-02-09T11:34:00Z | |
| dc.date.issued | 2019-03-21 | |
| dc.description.abstract | BRCA1 functions at two distinct steps during homologous recombination (HR). Initially, it promotes DNA end resection, and subsequently it recruits the PALB2 and BRCA2 mediator complex, which stabilizes RAD51-DNA nucleoprotein filaments. Loss of 53BP1 rescues the HR defect in BRCA1-deficient cells by increasing resection, suggesting that BRCA1's downstream role in RAD51 loading is dispensable when 53BP1 is absent. Here we show that the E3 ubiquitin ligase RNF168, in addition to its canonical role in inhibiting end resection, acts in a redundant manner with BRCA1 to load PALB2 onto damaged DNA. Loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, and it predisposes BRCA1 heterozygous mice to cancer. BRCA1+/-RNF168-/- cells lack RAD51 foci and are hypersensitive to PARP inhibitor, whereas forced targeting of PALB2 to DNA breaks in mutant cells circumvents BRCA1 haploinsufficiency. Inhibiting the chromatin ubiquitin pathway may, therefore, be a synthetic lethality strategy for BRCA1-deficient cancers. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | We thank Sergio Ruiz Macias, Avinash Bhandoola, Haico van Attikum, Niels Mailand, and Nussenzweig lab members for stimulating discussions; Yaakov Maman and Sriram Sridharan for help with statistical analysis; Richard Baer and Thomas Ludwig for BRCA1+/Delta 2 mice; and Jennifer Wise, Kelly Smith, Raymond Hui, and Breana Myers for assistance with animal work. M. Murga was funded by a grant from the Salvador Madariaga Program (PRX18/00364) from the Spanish Ministry of Education, Culture and Sports, within the framework of the National Program of Talent Promotion and its usefulness in R&D&I, National Mobility Subprogram, National Plan of R&D&I. The A.N. laboratory is supported by the Intramural Research Program of the NIH, an Ellison Medical Foundation Senior Scholar in Aging Award (AG-SS-2633-11), the Department of Defense Idea Expansion (W81XWH-15-2-006) and Breakthrough (W81XWH-16-1-599) Awards, the Alex Lemonade Stand Foundation Award, and an NIH Intramural FLEX Award. The work was also supported by the Rutgers Cancer Institute and the NCI-CCR Partnership on DNA Repair and Genomic Instability in Cancer. | es_ES |
| dc.format.number | 6 | es_ES |
| dc.format.page | 1267 | es_ES |
| dc.format.volume | 73 | es_ES |
| dc.identifier.citation | Mol Cell . 2019 ;73(6):1267-1281. | es_ES |
| dc.identifier.doi | 10.1016/j.molcel.2018.12.010 | es_ES |
| dc.identifier.e-issn | 1097-4164 | es_ES |
| dc.identifier.journal | Molecular cell | es_ES |
| dc.identifier.pubmedID | 30704900 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/17692 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Cell Press | |
| dc.relation.publisherversion | https://doi.org/10.1016/j.molcel.2018.12.010 | es_ES |
| dc.repisalud.institucion | CNIO | es_ES |
| dc.repisalud.orgCNIO | CNIO::Grupos de investigación::Grupo de Inestabilidad Genómica | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.mesh | Haploinsufficiency | es_ES |
| dc.subject.mesh | Ubiquitination | es_ES |
| dc.subject.mesh | Animals | es_ES |
| dc.subject.mesh | BRCA1 Protein | es_ES |
| dc.subject.mesh | BRCA2 Protein | es_ES |
| dc.subject.mesh | Cell Line, Tumor | es_ES |
| dc.subject.mesh | Chromatin | es_ES |
| dc.subject.mesh | DNA Damage | es_ES |
| dc.subject.mesh | Fanconi Anemia Complementation Group N Protein | es_ES |
| dc.subject.mesh | Female | es_ES |
| dc.subject.mesh | Fibroblasts | es_ES |
| dc.subject.mesh | Mice | es_ES |
| dc.subject.mesh | Mice, Inbred C57BL | es_ES |
| dc.subject.mesh | Mice, Knockout | es_ES |
| dc.subject.mesh | Mutation | es_ES |
| dc.subject.mesh | Neoplasms | es_ES |
| dc.subject.mesh | Poly(ADP-ribose) Polymerase Inhibitors | es_ES |
| dc.subject.mesh | Rad51 Recombinase | es_ES |
| dc.subject.mesh | Recombinational DNA Repair | es_ES |
| dc.subject.mesh | Tumor Suppressor p53-Binding Protein 1 | es_ES |
| dc.subject.mesh | Ubiquitin-Protein Ligases | es_ES |
| dc.title | BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation. | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 109ab297-8df3-458e-9a03-0dd210ea8e09 | |
| relation.isAuthorOfPublication.latestForDiscovery | 109ab297-8df3-458e-9a03-0dd210ea8e09 | |
| relation.isFunderOfPublication | 41383d53-27b2-4b36-a8d4-ead2ae8fe63b | |
| relation.isFunderOfPublication | 6081a0d0-d423-4510-b1af-a52eac0c92e4 | |
| relation.isFunderOfPublication | 8b5eb01a-f061-4bf4-8399-c5812208bb3b | |
| relation.isFunderOfPublication | b589134c-ce3e-4f64-a3f5-83d0a7eb706a | |
| relation.isFunderOfPublication.latestForDiscovery | 41383d53-27b2-4b36-a8d4-ead2ae8fe63b | |
| relation.isPublisherOfPublication | aea619d1-42a6-47f8-84e2-6bc27d6f8300 | |
| relation.isPublisherOfPublication.latestForDiscovery | aea619d1-42a6-47f8-84e2-6bc27d6f8300 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- brca1haploinsufficiency_2019.pdf
- Size:
- 3.58 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo principal


